These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20215826)

  • 61. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer.
    Kawahara T; Yokomizo Y; Ito Y; Ito H; Ishiguro H; Teranishi J; Makiyama K; Miyoshi Y; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Feb; 16():111. PubMed ID: 26883640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.
    Kawahara T; Fukui S; Sakamaki K; Ito Y; Ito H; Kobayashi N; Izumi K; Yokomizo Y; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Yao M; Miyamoto H; Uemura H
    Oncotarget; 2015 Oct; 6(31):32169-76. PubMed ID: 26359354
    [TBL] [Abstract][Full Text] [Related]  

  • 64. RegNetB: predicting relevant regulator-gene relationships in localized prostate tumor samples.
    Alvarez A; Woolf PJ
    BMC Bioinformatics; 2011 Jun; 12():243. PubMed ID: 21682879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?
    Cindolo L; Franco R; Cantile M; Schiavo G; Liguori G; Chiodini P; Salzano L; Autorino R; Di Blasi A; Falsaperla M; Feudale E; Botti G; Gallo A; Cillo C
    Eur Urol; 2007 Nov; 52(5):1365-73. PubMed ID: 17126478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The significance of LMO2 expression in the progression of prostate cancer.
    Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
    J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
    Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
    Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of NSAID-activated gene 1 expression in prostate cancer.
    Kawahara T; Ishiguro H; Hoshino K; Teranishi J; Miyoshi Y; Kubota Y; Uemura H
    Urol Int; 2010; 84(2):198-202. PubMed ID: 20215826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer.
    Wang X; Baek SJ; Eling TE
    Biochem Pharmacol; 2013 Mar; 85(5):597-606. PubMed ID: 23220538
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents.
    Yang MH; Kim J; Khan IA; Walker LA; Khan SI
    Life Sci; 2014 Apr; 100(2):75-84. PubMed ID: 24530873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gonadotropins and prostate cancer: revisited.
    Thwaini A; Naase M; Chinegwundoh F; Baithun S; Ghali L; Shergill I; Iles R
    Urol Int; 2006; 77(4):289-96. PubMed ID: 17135776
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.